Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

McGill University

$321,300.00

A computational assay for risk and progression in Parkinson's disease

FY 2017-18

Summary
Parkinson's disease (PD) is the second most common neurodegenerative disease, affecting more than 1% of the Canadian population. PD is marked by a progressive spread of atrophy from the midbrain to subcortical structures and eventually, to the cerebral cortex. The motor and cognitive consequences of PD are devastating, yet symptom severity is impossible to predict. Why some patients develop purely motor symptoms, while others develop affective and cognitive symptoms, remains a mystery. Recent discoveries suggest that PD may be caused by neuron to neuron spreading of an endogenous protein, alpha-synuclein, which misfolds and aggregates, causing damage and cell death. An exciting possibility is that an individual's clinical phenotype depends on which large-scale brain networks are targeted by this protein abnormality. Here we propose to integrate clinical measures, neuroimaging and genetics to predict spreading patterns of alpha-synuclein and the emergence of clinical symptoms. Key deliverables include (a) statistical methods to identify atrophy patterns and at-risk patients, and (b) computational methods to infer spreading patterns and predict future atrophy. Currently, little is known about the large-scale network mechanisms driving the spread of neurodegeneration and emergence of symptoms, so the proposed project will offer important insight into designing novel therapies to slow or divert disease progression.
Program
Project Grant
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
371682
Name
Misic Bratislav
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Systems & Circuits Neurosciences - A
Projecttitle
A computational assay for risk and progression in Parkinson's disease
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$321,300
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Computational Medicine; Disease Trajectory; Magnetic Resonance Imaging; Neurodegeneration; Neuroimaging; Statistical Learning; Subtyping
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disease, affecting more than 1% of the Canadian population. PD is marked by a progressive spread of atrophy from the midbrain to subcortical structures and eventually, to the cerebral cortex. The motor and cognitive consequences of PD are devastating, yet symptom severity is impossible to predict. Why some patients develop purely motor symptoms, while others develop affective and cognitive symptoms, remains a mystery. Recent discoveries suggest that PD may be caused by neuron to neuron spreading of an endogenous protein, alpha-synuclein, which misfolds and aggregates, causing damage and cell death. An exciting possibility is that an individual's clinical phenotype depends on which large-scale brain networks are targeted by this protein abnormality. Here we propose to integrate clinical measures, neuroimaging and genetics to predict spreading patterns of alpha-synuclein and the emergence of clinical symptoms. Key deliverables include (a) statistical methods to identify atrophy patterns and at-risk patients, and (b) computational methods to infer spreading patterns and predict future atrophy. Currently, little is known about the large-scale network mechanisms driving the spread of neurodegeneration and emergence of symptoms, so the proposed project will offer important insight into designing novel therapies to slow or divert disease progression.
Competitiondate
201709
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Misic, Bratislav
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $321,300~ $0~
McGill University - $321,300 Grant (2017-18) | Canada Spends